About UPMC Hillman Cancer Center Magee Womens Hospital
"UPMC Hillman Cancer Center - Oakland (Medical Oncology) is a Cancer Treatment Center located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."
Clinical Trials at UPMC Hillman Cancer Center Magee Womens Hospital
During the past decade, UPMC Hillman Cancer Center Magee Womens Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center Magee Womens Hospital"
#1 collaborator was "University of South Florida" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UPMC Hillman Cancer Center Magee Womens Hospital
According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center Magee Womens Hospital" are
"DCIS" (1 trials) and "Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center Magee Womens Hospital" in a lesser frequency.
Clinical Trials Intervention Types at UPMC Hillman Cancer Center Magee Womens Hospital
Most popular intervention types in "UPMC Hillman Cancer Center Magee Womens Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "APR-246" (1 trials), "Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)" (1 trials) and "Treatment Recommendation Surveys" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UPMC Hillman Cancer Center Magee Womens Hospital
The vast majority of trials in "UPMC Hillman Cancer Center Magee Womens Hospital" are
2 trials for "Female" genders.
Clinical Trials Status at UPMC Hillman Cancer Center Magee Womens Hospital
Currently, there are NaN active trials in "UPMC Hillman Cancer Center Magee Womens Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in UPMC Hillman Cancer Center Magee Womens Hospital,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Hillman Cancer Center Magee Womens Hospital, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".